Our group previously reported that the σ2R/TMEM97 is a good biomarker for measuring the proliferative status of cancer cells, which is defined as the ratio of the density of receptors in proliferating (P) versus quiescent (Q) cancer cells [13]. The gene discussed is TMEM97; the disease is cancer.